<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://genmapp.org/GPML/2010a" Name="Metabolism of lipids and lipoproteins" Data-Source="Reactome - http://www.reactome.org" Version="release 35" Author="Jassal, B, Gillespie, ME, Gopinathrao, G, D'Eustachio, P" Maintainer="D'Eustachio, P, Joshi-Tope, G" Email="deustp01@nyumc.org" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Lipids are hydrophobic but otherwise chemically diverse molecules that play a wide variety of roles in human biology. They include ketone bodies, fatty acids, triacylglycerols, phospholipids and sphingolipids, eicosanoids, cholesterol, bile salts, steroid hormones, and fat-soluble vitamins, and function as a major source of energy (fatty acids, triacylglycerols, and ketone bodies), are major constituents of cell membranes (cholesterol and phospholipids), play a major role in their own digestion and uptake (bile salts), and participate in numerous signaling and regulatory processes (steroid hormones, eicosanoids, and sphingolipids). Because of their poor solubility in water, most lipids in extracellular spaces in the human body are found as complexes with specific carrier proteins. Regulation of the formation and movement of these lipoprotein complexes is a critical aspect of human lipid metabolism, and lipoprotein abnormalities are associated with major human disease processes including atherosclerosis and diabetes.&lt;p&gt;The central steroid in human biology is cholesterol, obtained from animal fats consumed in the diet or synthesized de novo from acetyl-coenzyme A. (Vegetable fats contain various sterols but no cholesterol.) Cholesterol is an essential constituent of lipid bilayer membranes and is the starting point for the biosyntheses of bile acids and salts, steroid hormones, and vitamin D. Bile acids and salts are mostly synthesized in the liver. They are released into the intestine and function as detergents to solubilize dietary fats. Steroid hormones are mostly synthesized in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). At the same time, chronically elevated cholesterol levels in the body are associated with the formation of atherosclerotic lesions and hence increased risk of heart attacks and strokes. The human body lacks a mechanism for degrading excess cholesterol, although an appreciable amount is lost daily in the form of bile salts and acids that escape recycling.&lt;p&gt;Aspects of lipid metabolism currently annotated in Reactome include lipid digestion, mobilization, and transport; fatty acid, triacylglycerol, and ketone body metabolism; peroxisomal lipid metabolism; sphingolipid metabolism; prostanoid metabolism; cholesterol biosynthesis; bile acid and bile salt metabolism; and steroid hormone biosynthesis.</Comment>
  <Comment Source="WikiPathways-category">Metabolic Process</Comment>
  <Graphics BoardWidth="4259.75" BoardHeight="6985.0"/>
  <DataNode TextLabel="Lipid digestion, &#10;mobilization, and &#10;transport&#10;" GraphId="n1_REACTOME_73923" Type="Pathway">
    <Comment Source="WikiPathways-description">Processes annotated here include the digestion of dietary lipids, sterol uptake, the formation and turnover of lipoproteins (chylomicrons, VLDL, LDL, and HDL), and the mobilization of fatty acids through the action of hormone-sensitive lipase.</Comment>
    <Graphics CenterX="374.5" CenterY="72.0" Width="119.0" Height="62.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_602"/>
  </DataNode>
  <DataNode TextLabel="Fatty acid, &#10;triacylglycerol, and &#10;ketone body &#10;metabolism&#10;" GraphId="n2_REACTOME_535734" Type="Pathway">
    <Graphics CenterX="206.0" CenterY="127.5" Width="132.0" Height="83.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_22279"/>
  </DataNode>
  <DataNode TextLabel="Peroxisomal lipid &#10;metabolism&#10;" GraphId="n3_REACTOME_390918" Type="Pathway">
    <Comment Source="WikiPathways-description">In humans, the catabolism of phytanate, pristanate, and very long chain fatty acids as well as the first four steps of the biosynthesis of plasmalogens are catalyzed by peroxisomal enzymes. Defects in any of these enzymes or in the assembly of peroxisomes are associated with severe developmental disorders (Wanders and Watherham 2006).</Comment>
    <BiopaxRef>lit_389650</BiopaxRef>
    <Graphics CenterX="95.0" CenterY="224.5" Width="114.0" Height="55.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_16957"/>
  </DataNode>
  <DataNode TextLabel="Sphingolipid &#10;metabolism&#10;" GraphId="n4_REACTOME_428157" Type="Pathway">
    <Comment Source="WikiPathways-description">Sphingolipids are derivatives of long chain sphingoid bases such as sphingosine (trans-1,3-dihydroxy 2-amino-4-octadecene), an 18-carbon unsaturated amino alcohol which is the most abundant sphingoid base in mammals. Amide linkage of a fatty acid to sphingosine yields ceramides. Esterification of phosphocholine to ceramides yields sphingomyelin, and ceramide glycosylation yields glycosylceramides. Introduction of sialic acid residues yields gangliosides. These molecules appear to be essential components of cell membranes, and intermediates in the pathways of sphingolipid synthesis and breakdown modulate processes including apoptosis and T cell trafficking.&lt;p&gt;While sphingolipids are abundant in a wide variety of foodstuffs, these dietary molecules are mostly degraded by the intestinal flora and intestinal enzymes. The body primarily depends on de novo synthesis for its sphingolipid supply (Hannun and Obeid 2008; Merrill 2002). De novo synthesis proceeds in four steps: the condensation of palmitoyl-CoA and serine to form 3-ketosphinganine, the reduction of 3-ketosphinganine to sphinganine, the acylation of sphinganine with a long-chain fatty acyl CoA to form dihydroceramide, and the desaturation of dihydroceramide to form ceramide.&lt;p&gt;Other sphingolipids involved in signaling are derived from ceramide and its biosynthetic intermediates. These include sphinganine (dihydrosphingosine) 1-phosphate, phytoceramide, sphingosine, and sphingosine 1-phosphate.&lt;p&gt;Sphingomyelin is synthesized in a single step in the membrane of the Golgi apparatus from ceramides generated in the endoplasmic reticulum (ER) membrane and transferred to the Golgi by CERT (ceramide transfer protein), an isoform of COL4A3BP that is associated with the ER membrane as a complex with PPM1L (protein phosphatase 1-like) and VAPA or VAPB (VAMP-associated proteins A or B). Sphingomyelin synthesis appears to be regulated primarily at the level of this transport process through the reversible phosphorylation of CERT (Saito et al. 2008).&lt;br&gt;</Comment>
    <BiopaxRef>lit_428160</BiopaxRef>
    <BiopaxRef>lit_428144</BiopaxRef>
    <BiopaxRef>lit_429720</BiopaxRef>
    <Graphics CenterX="216.5" CenterY="224.0" Width="89.0" Height="52.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_19323"/>
  </DataNode>
  <DataNode TextLabel="Prostanoid &#10;metabolism&#10;" GraphId="n5_REACTOME_209962" Type="Pathway">
    <Comment Source="WikiPathways-description">Prostanoid hormones are formed from the precursor arachidonic acid (AA) in the local environment. This happens in three stages;&lt;br&gt;1. AA is mobilized from precursor lipids by lipases&lt;br&gt;2. AA is converted to the prostaglandin PGH2 by PGH synthase&lt;br&gt;3. PGH2 is isomerized or reduced to the biologically active prostanoids such as PGD2, PGE2, prostacyclin and thromboxane A2.</Comment>
    <BiopaxRef>lit_378989</BiopaxRef>
    <BiopaxRef>lit_266078</BiopaxRef>
    <Graphics CenterX="334.5" CenterY="224.5" Width="89.0" Height="49.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_15369"/>
  </DataNode>
  <DataNode TextLabel="Cholesterol &#10;biosynthesis&#10;" GraphId="n6_REACTOME_191273" Type="Pathway">
    <Comment Source="WikiPathways-description">Cholesterol is synthesized de novo from from acetyl CoA. The overall synthetic process is outlined in the figure below. Enzymes whose regulation plays a major role in determining the rate of cholesterol synthesis in the body are highlighted in red, and connections to other metabolic processes are indicated. The transformation of lanosterol into cholesterol requires multiple steps, including the removal of three methyl groups, the reduction of one double bond and the migration of another. These reactions may not occur in a single fixed order in the body, so the linear pathway laid out here following the work of Gaylor and colleagues (Gaylor 2002) is an oversimplification of the process that occurs in vivo. Defects in several of the enzymes involved in this process are associated with human disease and have provided useful insights into the regulatory roles of cholesterol and its synthetic intermediates in human development (Herman 2003; Song et al. 2005).</Comment>
    <BiopaxRef>lit_194670</BiopaxRef>
    <BiopaxRef>lit_196410</BiopaxRef>
    <BiopaxRef>lit_191376</BiopaxRef>
    <BiopaxRef>lit_191396</BiopaxRef>
    <BiopaxRef>lit_191583</BiopaxRef>
    <Graphics CenterX="523.5" CenterY="127.0" Width="93.0" Height="54.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_9405"/>
  </DataNode>
  <DataNode TextLabel="Bile acid and bile salt &#10;metabolism&#10;" GraphId="n7_REACTOME_194068" Type="Pathway">
    <Comment Source="WikiPathways-description">In a healthy adult human, about 500 mg of cholesterol is converted to bile salts daily. Newly synthesized bile salts are secreted into the bile and released into the small intestine where they emulsify dietary fats (Russell 2003). About 95% of the bile salts in the intestine are recovered and returned to the liver (Kullak-Ublick et al. 2004; Trauner and Boyer 2002). The major pathway for bile salt synthesis in the liver begins with the conversion of cholesterol to 7alpha-hydroxycholesterol. Bile salt synthesis can also begin with the synthesis of an oxysterol - 24-hydroxycholesterol or 27-hydroxycholesterol. In the body, the initial steps of these two pathways occur in extrahepatic tissues, generating intermediates that are transported to the liver and converted to bile salts via the 7alpha-hydroxycholesterol pathway. These extrahepatic pathways contribute little to the total synthesis of bile salts, but are thought to play important roles in extrahepatic cholesterol homeostasis (Javitt 2002).</Comment>
    <BiopaxRef>lit_193474</BiopaxRef>
    <BiopaxRef>lit_192080</BiopaxRef>
    <BiopaxRef>lit_194094</BiopaxRef>
    <BiopaxRef>lit_193584</BiopaxRef>
    <Graphics CenterX="478.0" CenterY="224.5" Width="128.0" Height="53.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_11040"/>
  </DataNode>
  <DataNode TextLabel="Metabolism of steroid &#10;hormones and vitamins A &#10;and D&#10;" GraphId="n8_REACTOME_196071" Type="Pathway">
    <Comment Source="WikiPathways-description">Steroid hormones are synthesized primarily in the adrenal gland and gonads. They regulate energy metabolism and stress responses (glucocorticoids), salt balance (mineralocorticoids), and sexual development and function (androgens and estrogens). All steroids are synthesized from cholesterol. Steroid hormone synthesis is largely regulated at the initial steps of cholesterol mobilization and transport into the mitochondrial matrix for conversion to pregnenolone. In the body, the fate of pregnenolone is tissue-specific: in the zona fasciculata of the adrenal cortex it is converted to cortisol, in the zona glomerulosa to aldosterone, and in the gonads to testosterone and then to estrone and estradiol. These pathways are outlined in the figure below, which also diagrams the sites on the cholesterol molecule that undergo modification in the course of these reactions.&lt;p&gt;Vitamin D3 (cholecalciferol) is a steroid hormone that plays a role in regulating calcium and bone metabolism. The processes by which it is synthesized, modified, and transported in the body are annotated here.</Comment>
    <BiopaxRef>lit_193094</BiopaxRef>
    <Graphics CenterX="630.5" CenterY="224.0" Width="147.0" Height="64.0" ZOrder="32768" FillColor="ccffcc" FontSize="12" Valign="Middle"/>
    <Xref Database="Reactome" ID="REACT_11057"/>
  </DataNode>
  <Line GraphId="e_10">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="312.5" Y="91.0" GraphRef="n1_REACTOME_73923" RelX="-1.0420168067226891" RelY="0.6129032258064516"/>
      <Point X="275.0" Y="104.5" GraphRef="n2_REACTOME_535734" RelX="1.0454545454545454" RelY="-0.5542168674698795" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="509.5" Y="157.0" GraphRef="n6_REACTOME_191273" RelX="-0.3010752688172043" RelY="1.1111111111111112"/>
      <Point X="490.0" Y="195.5" GraphRef="n7_REACTOME_194068" RelX="0.1875" RelY="-1.0943396226415094" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_12">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="553.5" Y="157.0" GraphRef="n6_REACTOME_191273" RelX="0.6451612903225806" RelY="1.1111111111111112"/>
      <Point X="593.5" Y="189.0" GraphRef="n8_REACTOME_196071" RelX="-0.5034013605442177" RelY="-1.09375" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_13">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="261.0" Y="172.5" GraphRef="n2_REACTOME_535734" RelX="0.8333333333333334" RelY="1.0843373493975903"/>
      <Point X="299.5" Y="197.5" GraphRef="n5_REACTOME_209962" RelX="-0.7865168539325843" RelY="-1.1020408163265305" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_14">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="209.0" Y="172.5" GraphRef="n2_REACTOME_535734" RelX="0.045454545454545456" RelY="1.0843373493975903"/>
      <Point X="212.5" Y="195.0" GraphRef="n4_REACTOME_428157" RelX="-0.0898876404494382" RelY="-1.1153846153846154" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_15">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="157.0" Y="172.5" GraphRef="n2_REACTOME_535734" RelX="-0.7424242424242424" RelY="1.0843373493975903"/>
      <Point X="127.0" Y="194.5" GraphRef="n3_REACTOME_390918" RelX="0.5614035087719298" RelY="-1.0909090909090908" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_17">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="437.5" Y="94.0" GraphRef="n1_REACTOME_73923" RelX="1.0588235294117647" RelY="0.7096774193548387"/>
      <Point X="474.5" Y="109.0" GraphRef="n6_REACTOME_191273" RelX="-1.053763440860215" RelY="-0.6666666666666666" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <Line GraphId="e_18">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="275.0" Y="127.5" GraphRef="n2_REACTOME_535734" RelX="1.0454545454545454" RelY="0.0"/>
      <Point X="474.5" Y="127.0" GraphRef="n6_REACTOME_191273" RelX="-1.053763440860215" RelY="0.0" ArrowHead="Arrow"/>
    </Graphics>
  </Line>
  <InfoBox CenterX="3872.5" CenterY="6350.0"/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_193094">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15583024</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Payne, AH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hales, DB</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endocr Rev 25:947-70</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_428144">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12011104</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Merrill AH, Jr</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 277:25843-6</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_194094">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12663868</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bile salt transporters: molecular characterization, function, and regulation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Boyer, JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Trauner, M</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Physiol Rev 83:633-671</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_266078">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17623009</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biosynthesis and metabolism of leukotrienes</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Murphy, RC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GijÃ³n, MA</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem J 405:379-95</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_429720">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18165232</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Saito, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Matsui, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kawano, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kumagai, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tomishige, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hanada, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Echigo, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tamura, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kobayashi, T</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 283:6584-93</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_196410">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12668600</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Herman, GE</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hum Mol Genet 12:R75-88</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_191396">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1390320</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1992</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cholesterol biosynthesis and metabolism</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Russell, DW</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cardiovasc Drugs Ther 6:103-10</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_191583">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16054061</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2005</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Song, BL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Javitt, NB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DeBose-Boyd, RA</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Metab 1:179-89</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_192080">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12543708</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The enzymes, regulation, and genetics of bile acid synthesis</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Russell, DW</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Biochem 72:137-74</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_193474">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14699511</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enterohepatic bile salt transporters in normal physiology and liver disease</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kullak-Ublick, GA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stieger, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meier, PJ</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gastroenterology 126:322-42</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_428160">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18216770</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Principles of bioactive lipid signalling: lessons from sphingolipids</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hannun, YA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Obeid, LM</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nat Rev Mol Cell Biol 9:139-50</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_194670">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11969204</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Membrane-bound enzymes of cholesterol synthesis from lanosterol</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gaylor, JL</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Biophys Res Commun 292:1139-46</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_191376">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3524618</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1986</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of cholesterol biosynthesis</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rudney, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sexton, RC</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Nutr 6:245-72</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_193584">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11969205</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cholesterol, hydroxycholesterols, and bile acids</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Javitt, NB</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Biophys Res Commun 292:1147-53</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_389650">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16756494</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry of mammalian peroxisomes revisited</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wanders, RJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Waterham, HR</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Biochem 75:295-332</bp:SOURCE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="lit_378989">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1324603</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1992</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Prostanoid biosynthesis and mechanisms of action</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Smith, WL</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Am J Physiol 263:F181-91</bp:SOURCE>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>lipoprotein metabolic pathway</bp:TERM><bp:ID>PW:0000482</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>